Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries

British Journal of Pharmacology

Volumn 143, Issue 8, 2004, Pages 976-986

  Prieto, Dolores ^a   Rivera De Los Arcos, Luis ^a   Martínez, Pilar ^b   Benedito, Sara ^a   García Sacristán, Albino ^a   Hernández, Medardo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Endothelium; Nerves; Neuropeptide Y; Noradrenaline; NPY Y 1 and Y 2 receptors; Penile small artery; Potentiation; Relaxation

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; COCAINE; GR 231118; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y [13-36]; NEUROPEPTIDE Y [24-36]; NEUROPEPTIDE Y [3-36]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR AGONIST; NEUROPEPTIDE Y1 RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR AGONIST; NEUROPEPTIDE Y2 RECEPTOR ANTAGONIST; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NORADRENALIN; OMEGA CONOTOXIN GVIA; PANCREAS POLYPEPTIDE; PROPRANOLOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG POTENTIATION; DRUG SELECTIVITY; ELECTRIC FIELD; ELECTROSTIMULATION; HORSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PENIS ARTERY; PRIORITY JOURNAL;

ANIMALS; ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HORSES; MALE; NOREPINEPHRINE; PENIS; RECEPTORS, NEUROPEPTIDE Y; VASOCONSTRICTION; VASODILATION;

EID: 11244286043     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706005     Document Type: Article

References (42)

1. 1 antagonist BIBP 3226. Br. J. Pharmacol., 116, 2245-2250.
2. ANDERSSON, K.-E. & WAGNER, G. (1995). Physiology of penile erection. Physiol. Rev., 75, 191-236.
3. ANDRIANTSITOHAINA, R. & STOCLET, J.C. (1988). Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries. Br. J. Pharmacol., 95, 419-428.
4. BAO, L., KOPP, J., ZHANG, X., XU, Z.O.D., ZHANG, L.F., WONG, H., WALSH, J. & HÖKFELT, T. (1997). Localization of neuropeptide Y Y1 receptors in cerebral blood vessels. Proc. Natl. Acad. Sci. U.S.A., 94, 12661-12666.
5. CARRILLO, Y., FERNANDEZ, E., DAIL, W.O. & WALTON, G. (1991). Distribution and origin of neuropeptide Y-immunoreactive fibers in the penis of the rat. Cell Tissue Res., 264, 127-132.
6. DANIELS, A.J., GRIZZLE, M.K., WIARD, R.P., MATHEWS, J.E. & HEYER, D. (2002). Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 antagonist. Regul. Pept., 106, 47-54.
7. DOODS, H.N., GAIDA, W., WIELAND, H.A., DOLLINGER, H., SCHNORRENBERG, G., ESSER, F., ENGEL, W., EBERLEIN, W. & RUDOLF, K. (1999). BIIE0246: a selective and high affinity neuropeptide Y2 receptor antagonist. Eur. J. Pharmacol., 384, R3-R5.
8. 1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther., 275, 136-142.
9. EDVINSSON, L., EKBLAD, E., HAKANSON, R. & WAHLESTEDT, C. (1984). Neuropeptide Y potentiates the effects of various vasoconstrictor agents on rabbit blood vessels. Br. J. Pharmacol., 83, 519-525.
10. GEHLERT, D.R. (1998). Multiple receptors for the pancreatic polypeptide (PP-fold) family: Physiological implications. Proc. Soc. Exp. Biol. Med., 218, 7-22.
11. 1-selective antagonists, BIBP3226. Br. J. Pharmacol., 119, 1313-1318.
12. GIULIANO, F., BERNABE, J., JARDIN, A. & ROUSSEAU, J.-P. (1993). Antierectile role of sympathetic nervous system in rats. J. Urol., 150, 519-524.
13. GRADIN, K.A., LI, J.Y., ANDERSSON, O. & SIMONSEN, U. (2003). Enhanced Neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats. J. Vasc. Res., 40, 252-265.
14. HEDLUND, H. & ANDERSSON, K.-E. (1985). Effects of some peptides on isolated human penile erectile tissue and cavernous artery. Acta Physiol. Scand., 124, 413-419.
15. HSU, S.M., RAINE, L. & FANGER, H. (1981). The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580.
16. JACKEROTT, M. & LARSSON, L.I. (1997). Immunocytochemical localization of the NPY/PYY Y1 receptor in enteric neurons, endothelial cell, and endocrine-like cells of the rat intestinal tract. J. Histochem Cytochem., 45, 1643-1650.
17. KIRKEBY, H.J., JORGENSEN, J.C. & OTTENSEN, B. (1991). Neuropeptide Y (NPY) in human penile corpus cavernosum tissue and circumflex veins - occurrence and in vitro effects. J. Urol., 145, 605-609.
18. KIRKEBY, H.J., LUNDBECH, P.E., DJURHUUS, J.C & FORMAN, A. (1992). Effects of vasoactive intestinal peptide, peptide histidine methionine, and neuropeptide Y on intracavernous pressure in the rabbit. J. Urol., 40, 270-276.
19. KOBARI, M., FUKUCHI, Y., TOMITA, M., TANAHASHI, N., YAMAWAKI, T., TAKEDA, H. & MATSUOKA, S. (1993). Transient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide. Brain Res. Bull., 31, 443-448.
20. LIN, Q., ZOU, X., REN, Y., WANG, J., FANG, L. & WILLIS, W.D. (2004). Involvement of neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience, 123, 337-347.
21. 1 receptor mechanisms in sympathetic vascular control. Acta Physiol. Scand. Suppl., 636, 1-55.
22. 2 receptor antagonist, in vivo. Br. J. Pharmacol., 133, 1073-1080.
23. 2 receptor evidenced by BIIE0246. Eur. J. Pharmacol., 439, 113-119.
24. MICHEL, M.C., BECK-SICKINGER, A., COX, H., DOODS, H.N., HERZOG, H., LARHAMAR, D., QUIRION, R., SCHWARTZ, T. & WESTFALL, T. (1998). XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, PYY and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
25. NILSSON, T., LIND, H., BRUNKVALL, J. & EDVINSSON, L. (2000). Vasodilatation in human subcutaneous arteries induced by neuropeptide Y Y1 receptors is nitric oxide dependent. Can. J. Physiol. Pharmacol., 78, 251-255.
26. PRIETO, D., BENEDITO, S., SIMONSEN, U. & NYBORG, N.C.B. (1991). Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries. Br. J. Pharmacol., 102, 754-758.
27. PRIETO, D., BUUS, C., MULVANY, M.J. & NILSSON, H. (1997a). Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential. J. Physiol., 502, 281-292.
28. PRIETO, D., BUUS, C., MULVANY, M.J. & NILSSON, H. (2000). Neuropeptide Y regulates intracellular calcium through different signalling pathways linked to a Y1-receptor in rat mesenteric small arteries. Br. J. Pharmacol., 129, 1689-1699.
29. PRIETO, D., GARCÍA-SACRISTÁN, A. & SIMONSEN, U. (1998a). Characterization of NPY receptors mediating in rat intramyocardial arteries. Regul. Pept., 75, 155-160.
30. PRIETO, D., HERNÁNDEZ, M., RIVERA, L., GARCÍA- SACRISTÁN, A. & SIMONSEN, U. (1997b). Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries. Regul. Pept., 69, 155-165.
31. + channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries. Br. J. Pharmacol., 123, 1609-1620.
32. PRIETO, D., SIMONSEN, U. & NYBORG, N.C.B. (1995). Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine retinal isolated arteries. Br. J. Pharmacol., 116, 2729-2737.
33. SCHMALBRUCH, H. & WAGNER, G. (1989). Vasoactive intestinal polypeptide (VIP) and neuropeptide Y (NPY)-containing fibres in the penile cavernous tissue of green monkeys (Cercopitthecus aethiops). Cell Tissue Res., 256, 529-541.
34. SCHOBER, D.A., VAN ABBEMA, A.M., SMILEY, D.L., BRUNS, R.F. & GEHLERT, D.R (1998). The neuropeptide Y Y-1 antagonist, 129U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y-4) receptor. Peptides, 19, 537-542.
35. SIMONSEN, U., GARCÍA-SACRISTÁN, A. & PRIETO, D. (2002). Penile arteries and erection. J. Vasc. Res., 39, 283-303.
36. SIMONSEN, U., PRIETO, D., HERNÁNDEZ, M., SAENZ DE TEJADA, I. & GARCÍA-SACRISTÁN, A. (1997). Adrenoceptor-mediated regulation of the contractility of horse penile resistance arteries. J. Vasc. Res., 34, 92-102.
37. SIMONSEN, U., PRIETO, D., SAENZ DE TEJADA, I. & GARCÍA- SACRISTÁN, A. (1995). Involvement of nitric oxide in the non-adrenergic neurotransmission of horse deep penile arteries. Br. J. Pharmacol., 116, 2582-2590.
38. TESSEL, R.E., MILLER, D.W., MISSE, G.A., DONG, X. & DOUGHTY, M.B. (1993). Characterization of vascular postsynaptic receptor function and regulation. 1. Neuropeptide Y-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies. J. Pharmacol. Exp. Ther., 265, 172-177.
39. TORFFVIT, O. & EDVINSSON, L. (1997). Blockade of nitric oxide decreases renal vasodilatory effect of in the insulin-treated diabetic rat. Pflüggers Arch., 434, 445-450.
40. WESPES, E., SCHIFFMANN, S., GILLOTEAUX, J., SCHULMAN, C., VIERENDEELS, G., MENU, R., PELLETIER, G., VAUDRY, H. & VANDERHAEGEN, J.J. (1988). Study of neuropeptide Y-containing nerve fibers in the human penis. Cell Tissue Res., 254, 69-74.
41. YOU, J., EDVINSSON, L. & BRYAM, R.M. (2001). Neuropeptide Y-mediated constriction and dilatation in rat middle cerebral arteries. J. Cereb. Blood Flow Metab., 21, 77-84.
42. ZUKOWSKA-GROJEC, Z., KARWATOWSKA-PROKOPCZUK, E., ROSE, W., RONE, J., MOVAFAGH, S., JI, H., YEH, Y., CHEN, W.T., KLEINMAN, H.K., GROUZMANN, E. & GRANT, D.S. (1998). Neuropeptide Y: a novel angiogenic factor from sympathetic nerves and endothelium. Circ. Res., 83, 187-195.